A comprehensive comparison between camelid nanobodies and single chain variable fragments
Abstract By the emergence of recombinant DNA technology, many antibody fragments have been developed devoid of undesired properties of natural immunoglobulins. Among them, camelid heavy-chain variable domains (VHHs) and single-chain variable fragments (scFvs) are the most favored ones. While scFv is...
Main Authors: | Yasaman Asaadi, Fatemeh Fazlollahi Jouneghani, Sara Janani, Fatemeh Rahbarizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-12-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-021-00332-6 |
Similar Items
-
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
by: Mehdi Arbabi-Ghahroudi
Published: (2022-04-01) -
Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
by: Mehdi Arbabi-Ghahroudi, et al.
Published: (2017-11-01) -
Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases
by: Carla F. C. Fernandes, et al.
Published: (2017-06-01) -
Generation and diversification of recombinant monoclonal antibodies
by: Keith F DeLuca, et al.
Published: (2021-12-01) -
Structure of a VHH isolated from a naïve phage display library
by: Brandy White, et al.
Published: (2019-03-01)